Diroximel Fumarate Shows Low GI Adverse Events in MS Diroximel Fumarate Shows Low GI Adverse Events in MS

The novel drug for relapsing multiple sclerosis is designed to reduce gastrointestinal events compared to dimethyl fumarate.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news